Selected research
Industry Research
Preterm Birth Prevention and Treatment Industry Research Report 2026
Market perspective
The global Preterm Birth Prevention and Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Preterm Birth Prevention and Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Preterm Birth Prevention and Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Preterm Birth Prevention and Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Preterm Birth Prevention and Treatment include Teva, Sanofi, Novartis, Merck & Co, Pfizer, Bayer, AbbVie, Viatris and Ferring Pharmaceutical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Preterm Birth Prevention and Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Preterm Birth Prevention and Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Preterm Birth Prevention and Treatment Market by Company
Teva
Sanofi
Novartis
Merck & Co
Pfizer
Bayer
AbbVie
Viatris
Ferring Pharmaceutical
Aurobindo Pharma
AMAG Pharmaceuticals
Allergan
Preterm Birth Prevention and Treatment Segment by Type
Progesterone Therapy
Tocolytics Therapy
Corticosteroid Therapy
Magnesium Sulfate Therapy
Antihypertensive Therapy
Other
Preterm Birth Prevention and Treatment Segment by Application
Hospital
Drugs Stores
Other
Preterm Birth Prevention and Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preterm Birth Prevention and Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Preterm Birth Prevention and Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preterm Birth Prevention and Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Preterm Birth Prevention and Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Progesterone Therapy
- Tocolytics Therapy
- Corticosteroid Therapy
- Magnesium Sulfate Therapy
- Antihypertensive Therapy
- Other
Applications
- Hospital
- Drugs Stores
- Other
Companies covered
- Teva
- Sanofi
- Novartis
- Merck & Co
- Pfizer
- Bayer
- AbbVie
- Viatris
- Ferring Pharmaceutical
- Aurobindo Pharma
- AMAG Pharmaceuticals
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Preterm Birth Prevention and Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Progesterone Therapy
- 2.2.3 Tocolytics Therapy
- 2.2.4 Corticosteroid Therapy
- 2.2.5 Magnesium Sulfate Therapy
- 2.2.6 Antihypertensive Therapy
- 2.2.7 Other
- 2.3 Preterm Birth Prevention and Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Drugs Stores
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Preterm Birth Prevention and Treatment Breakdown Data by Type
- 3.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2027-2032)
4 Preterm Birth Prevention and Treatment Breakdown Data by Application
- 4.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Preterm Birth Prevention and Treatment Market Perspective (2021-2032)
- 5.2 Global Preterm Birth Prevention and Treatment Growth Trends by Region
- 5.2.1 Global Preterm Birth Prevention and Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Preterm Birth Prevention and Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Preterm Birth Prevention and Treatment Market Dynamics
- 5.3.1 Preterm Birth Prevention and Treatment Industry Trends
- 5.3.2 Preterm Birth Prevention and Treatment Market Drivers
- 5.3.3 Preterm Birth Prevention and Treatment Market Challenges
- 5.3.4 Preterm Birth Prevention and Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue
- 6.1.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Preterm Birth Prevention and Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Preterm Birth Prevention and Treatment Head Office and Area Served
- 6.4 Global Preterm Birth Prevention and Treatment Players, Product Type & Application
- 6.5 Global Preterm Birth Prevention and Treatment Manufacturers Established Date
- 6.6 Global Preterm Birth Prevention and Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Preterm Birth Prevention and Treatment Market Size (2021-2032)
- 7.2 North America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
- 7.4 North America Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Preterm Birth Prevention and Treatment Market Size (2021-2032)
- 8.2 Europe Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
- 8.4 Europe Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Preterm Birth Prevention and Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Preterm Birth Prevention and Treatment Market Size (2021-2032)
- 10.2 South America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
- 10.4 South America Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Preterm Birth Prevention and Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva
- 12.1.1 Teva Company Information
- 12.1.2 Teva Business Overview
- 12.1.3 Teva Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.1.4 Teva Preterm Birth Prevention and Treatment Product Portfolio
- 12.1.5 Teva Recent Developments
- 12.2 Sanofi
- 12.2.1 Sanofi Company Information
- 12.2.2 Sanofi Business Overview
- 12.2.3 Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.2.4 Sanofi Preterm Birth Prevention and Treatment Product Portfolio
- 12.2.5 Sanofi Recent Developments
- 12.3 Novartis
- 12.3.1 Novartis Company Information
- 12.3.2 Novartis Business Overview
- 12.3.3 Novartis Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.3.4 Novartis Preterm Birth Prevention and Treatment Product Portfolio
- 12.3.5 Novartis Recent Developments
- 12.4 Merck & Co
- 12.4.1 Merck & Co Company Information
- 12.4.2 Merck & Co Business Overview
- 12.4.3 Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.4.4 Merck & Co Preterm Birth Prevention and Treatment Product Portfolio
- 12.4.5 Merck & Co Recent Developments
- 12.5 Pfizer
- 12.5.1 Pfizer Company Information
- 12.5.2 Pfizer Business Overview
- 12.5.3 Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.5.4 Pfizer Preterm Birth Prevention and Treatment Product Portfolio
- 12.5.5 Pfizer Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.6.4 Bayer Preterm Birth Prevention and Treatment Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 AbbVie
- 12.7.1 AbbVie Company Information
- 12.7.2 AbbVie Business Overview
- 12.7.3 AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.7.4 AbbVie Preterm Birth Prevention and Treatment Product Portfolio
- 12.7.5 AbbVie Recent Developments
- 12.8 Viatris
- 12.8.1 Viatris Company Information
- 12.8.2 Viatris Business Overview
- 12.8.3 Viatris Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.8.4 Viatris Preterm Birth Prevention and Treatment Product Portfolio
- 12.8.5 Viatris Recent Developments
- 12.9 Ferring Pharmaceutical
- 12.9.1 Ferring Pharmaceutical Company Information
- 12.9.2 Ferring Pharmaceutical Business Overview
- 12.9.3 Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.9.4 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product Portfolio
- 12.9.5 Ferring Pharmaceutical Recent Developments
- 12.10 Aurobindo Pharma
- 12.10.1 Aurobindo Pharma Company Information
- 12.10.2 Aurobindo Pharma Business Overview
- 12.10.3 Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.10.4 Aurobindo Pharma Preterm Birth Prevention and Treatment Product Portfolio
- 12.10.5 Aurobindo Pharma Recent Developments
- 12.11 AMAG Pharmaceuticals
- 12.11.1 AMAG Pharmaceuticals Company Information
- 12.11.2 AMAG Pharmaceuticals Business Overview
- 12.11.3 AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.11.4 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product Portfolio
- 12.11.5 AMAG Pharmaceuticals Recent Developments
- 12.12 Allergan
- 12.12.1 Allergan Company Information
- 12.12.2 Allergan Business Overview
- 12.12.3 Allergan Revenue in Preterm Birth Prevention and Treatment Business (2021-2026)
- 12.12.4 Allergan Preterm Birth Prevention and Treatment Product Portfolio
- 12.12.5 Allergan Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst